Skip to content

Bio availability study of Berberine in Manasamitra Vatakam: An ayurvedic herbomineral formulation

An Open Label and Single dose Pharmacokinetic Study for the assessment of Berberine in Manasamitra Vatakam, an Ayurvedic Herbo Mineral Formulation.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023267
Enrollment
12
Registered
2020-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Manasamitra Vatakam: Ayurvedic Herbomineral formulation,single dose of polyherbal formulation consisted of various plant extracts and minerals comprising the tablet weight id 182.5mg on

Sponsors

SRM Institute of Science and Technology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Willingness to provide written informed consent to participate in the study. Volunteers understanding the nature and purpose of the study and who are willing to comply with study procedures. Non-smokers or individuals who smoke less than 5 cigarettes per day. Teetotalers.Healthy individuals as evaluated by personal history, medical history and general clinical examination

Exclusion criteria

Exclusion criteria: History suggestive of cardiac, gastrointestinal, respiratory, hepatic, renal, endocrine, neurological, metabolic, psychiatric or hematological systems, judged to be clinically significant. Subject with clinically significant abnormal values of laboratory parameters.History of diabetes mellitus, tuberculosis and systemic hypertension. Subject who had participated in any other clinical study during the last 3 months.

Design outcomes

Primary

MeasureTime frame
The information regarding the ADME parameters of berberine in the investigation product i.e., Manasamitra Vatakam have not been investigated and hence the present study involves in determine the pharmacokinetic parameters from the healthy human male volunteers.Timepoint: 0min, 30min, 60min, 90min, 2H, 4H, 6H, 8H, 10H, 12H , 24H

Secondary

MeasureTime frame
The relation between the plasma concentration and the therapeutic effects are studied to employ the safety and efficacy of the formulation.Timepoint: 0min, 30min, 60min, 90min, 2H, 4H, 6H, 8H, 10H, 12H , 24H

Countries

India

Contacts

Public ContactSrikalyani Vemuri

SRM Institute of Science and Technology

dean.iiism@srmist.edu.in94441441210

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026